Merck 2014 Annual Report Download - page 110

105GROUP MANAGEMENT REPORT → REPORT ON ECONOMIC POSITION → Consumer Health
%Europe → 361.1
North America → 0.5
Emerging Markets → 385.8
Rest of World → 18.7
0
50
3
47
CONSUMER HEALTH →
SALES BY REGION – 2014
€ million / % of divisional sales
From a geographic perspective, the division’s two most important
regions, namely Emerging Markets and Europe, delivered solid or-
ganic growth rates. The Emerging Markets region, which accounts
for 50 % of sales (2013: 51 %) and is the division’s largest region,
posted organic sales growth of 7.1 % and a negative foreign ex-
change impact of – 4.6 %. Sales in this region thus increased by a
total of 2.5 % to €386 million (2013: €376 million). Neurobion®
in particular proved to be a growth driver and achieved double-
digit growth rates in Latin America. Sales benefited from the focus
on consumer-oriented marketing activities. For instance in the
growth market of Brazil, the anti-diarrheal Floratil® achieved a
double-digit growth rate. In Asia, the growth drivers included not
only Neurobion® but also the iron supplement Sangobion®. The
performance of these two brands was very strong particularly in
Indonesia and the Philippines.
In Europe, the Consumer Health division generated organic
sales growth of 4.6 % supported by positive foreign exchange
effects of 0.6 %, which led to an increase in sales to €361 million
(2013: €343million). Strong sales volumes of Femibion®, a nutri-
tional supplement for pregnant women, local brands in Germany
as well as Apaisyl®, a French brand of insect repellent and skin
care products, more than offset weaker demand for Bion® as well
as Nasivin®, which, for example, was impacted by a mild winter.
The share of divisional sales accounted for by Europe remained
constant at 47 % in 2014 (2013: 46 %).
CONSUMER HEALTH →
SALES COMPONENTS BY REGION – 2014
€ million / change in % Sales Organic growth
Exchange rate
effects
Acquisitions /
divestments Total change
Europe 361.1 4.6 0.6 – 5.2
North America 0.5 – 56.5 1.6 – – 54.9
Emerging Markets 385.8 7.1 – 4.6 – 2.5
Rest of World 18.7 – 8.0 – 5.3 – –13.3
Consumer Health 766.1 5.4 – 2.2 – 3.2